Showing 37,721 - 37,740 results of 69,285 for search '(( 01 ((1 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.80s Refine Results
  1. 37721
  2. 37722
  3. 37723
  4. 37724
  5. 37725
  6. 37726
  7. 37727
  8. 37728
  9. 37729
  10. 37730
  11. 37731
  12. 37732

    Supplementary Material for: Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study) by Distler M. (8332950)

    Published 2020
    “…After 6 months the median AFIRMM score decreased 50% from 52.0 to 26.0 in the omalizumab group versus 104.0–102.0 in the placebo group (<i>p</i> = 0.286); however, the difference was not significant (<i>p</i> = 0.941). …”
  13. 37733

    Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study by Yahia Al-Jebari (6796670)

    Published 2019
    “…Among children fathered by men with TGCC (<i>n</i> = 4,207), 184 had a CM. The risk of malformations was higher among children of fathers with TGCC compared with children fathered by men without TGCC (OR 1.28, 95% confidence interval [CI] 1.19–1.38, <i>p</i> = 0.001, 4.4% versus 3.5%). …”
  14. 37734

    EF-24 treatment significantly reduces cell viability in leukemia cell lines. by Ajeet P. Singh (22298432)

    Published 2025
    “…<p>(A) Relative cell viability measured using the Promega® CellTiter-Glo® luminescent assay shows a marked decrease in EF-24–treated cells compared to controls. …”
  15. 37735

    E2F-1 regulates AP-2α transcription by direct binding to the AP-2α promoter. by Vladislava O. Melnikova (242902)

    Published 2010
    “…Actin was used a loading control. (C) Transient expression of E2F-1 significantly decreased AP-2α protein levels in SB2 cells by 90%. …”
  16. 37736
  17. 37737
  18. 37738
  19. 37739
  20. 37740